Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2627 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
British Heart Foundation. (8/25/18). "Press Release: £30m Global Challenge Launched to Tackle Heart and Circulatory Diseases". 2018-08-25
BRAIN AG. (8/22/18). "Press Release: BRAIN AG Announces the Creation of SolasCure Ltd. to Continue Development of Aurase". Zwingenberg. 2018-08-22
Immunocore Ltd.. (8/20/18). "Press Release: Immunocore Announces Start of Phase I ImmTAC Study in Patients with Solid Tumours". Oxford & Conshohocken, PA. 2018-08-20
Abzena plc. (8/16/18). "Press Release: Recommended Cash Offer for Abzena plc [NOT FOR RELEASE WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION]". 2018-08-16
Abzena plc. (8/16/18). "Press Release: Update on Partial Monetisation of Abzena Inside Portfolio". Cambridge. 2018-08-16
Adaptimmune Therapeutics plc. (8/15/18). "Press Release: Third Dosing Cohort to Be Initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort". Philadeliphia, PA & Oxford. 2018-08-15
Blueberry Therapeutics Ltd.. (8/14/18). "Press Release: Blueberry Therapeutics Limited Closes £10m Funding to Support Development of Nanomedicines Portfolio". Alderley Park. 2018-08-14
Orchard Therapeutics Ltd.. (8/13/18). "Press Release: Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline". Boston, MA & London. 2018-08-13
Artios Pharma Ltd.. (8/10/18). "Press Release: Artios Pharma Announces $84 million (£65 million) Series B Financing. Financing Round Led by New Investors Andera Partners and LSP". 2018-08-10
Nabriva Therapeutics plc. (8/9/18). "Press Release: Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-08-09
Consilium Strategic Communications Ltd.. (8/8/18). "Press Release: Consilium – H1 2018 Update". Munich. 2018-08-08
GlaxoSmithKline plc. (8/7/18). "Press Release: Iain Mackay Appointed GSK Chief Financial Officer". London. 2018-08-07
Bruker Corporation. (8/6/18). "Press Release: Bruker Announces Ultra-High Field NMR Orders from Major NMR Infrastructure Investment in the UK". Billerica, MA. 2018-08-06
Arix Bioscience plc. (8/6/18). "Press Release: Arix Bioscience Announces First VIPE Investment". London. 2018-08-06
Adaptimmune Therapeutics plc. (8/2/18). "Press Release: Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update". Philadeliphia, PA & Oxford. 2018-08-02
Phico Therapeutics Ltd.. (8/1/18). "Press Release: Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project". Cambridge. 2018-08-01
ReViral Ltd.. (8/1/18). "Press Release: ReViral Announces Series B Investment. ReViral Announces US$55 Million Series B Fundraising to Advance RSV Clinical Studies". London. 2018-08-01
Medicines Discovery Catapult, The. (7/30/18). "Press Release: Medicines Discovery Catapult Appoints New Chair as It Moves into the Next Phase of Delivery alongside UK Biotech and Academia". 2018-07-30
GlaxoSmithKline plc. (7/27/18). "Press Release: CHMP Recommend Nucala (mepolizumab) for the Treatment of Severe Eosinophilic Asthma Paediatric Patients in Europe". London. 2018-07-27
Nabriva Therapeutics plc. (7/26/18). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million". Dublin & King of Prussia, PA. 2018-07-26
Healx Ltd.. (7/26/18). "Press Release: Healx Raises $10m as Investors Back AI to Find Rare Disease Treatments Faster". Cambridge. 2018-07-26
GlaxoSmithKline plc. (7/25/18). "Press Release: GSK and 23andMe Sign Agreement to Leverage Genetic Insights for the Development of Novel Medicines". 2018-07-25
Nabriva Therapeutics plc. (7/25/18). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2018-07-25
Peak Scientific Instruments Ltd.. (7/25/18). "Press Release: Peak Underlines Position as Leader in N2 Systems for Single Quad LC-MS with Genius SQ 24". 2018-07-25
GlaxoSmithKline plc. (7/25/18). "Press Release: GSK Delivers Improvements in Sales, Margins and Cash Flow in Q2 2018". London. 2018-07-25
GlaxoSmithKline plc. (7/24/18). "Press Release: GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-Cell Therapy Programme to GSK". 2018-07-24
Nabriva Therapeutics plc. (7/24/18). "Press Release: Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics". Dublin & King of Prussia, PA. 2018-07-24
Endomagnetics Ltd. (Endomag). (7/23/18). "Press Release: Endomag Raises $10 Million USD (£8m GBP) to Establish a New Standard of Breast Cancer Care". Cambridge & London. 2018-07-23
CN Bio Innovations Ltd.. (7/19/18). "Press Release: CN Bio Innovations’ Board Names David Hughes as next Chief Executive Officer". London. 2018-07-19
Agilent Technologies Inc.. (7/19/18). "Press Release: UK Border Force Deploys Agilent Resolve Handheld Raman Systems for Hazardous Material Detection". Santa Clara, CA. 2018-07-19
Axol Bioscience Ltd.. (7/17/18). "Press Release: Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes". Cambridge. 2018-07-17
Consilium Strategic Communications Ltd.. (7/17/18). "Press Release: Consilium Strategic Communications Advises Polyphor on its Successful CHF 155 Million (c. €130 Million) Fundraise and IPO on the SIX Swiss Exchange". London. 2018-07-17
Silence Therapeutics plc. (7/17/18). "Press Release: Silence Therapeutics Appoints David Horn Solomon as Chief Executive Officer". 2018-07-17
GlaxoSmithKline plc. (7/12/18). "Press Release: James Ford Appointed GSK General Counsel". London. 2018-07-12
OMass Technologies Ltd.. (7/11/18). "Press Release: OMass Technologies Announces Publication Demonstrating the Impact of Lipid Interactions on GPCR Signalling in Nature". Oxford. 2018-07-11
Locust Walk Partners, LLC. (7/11/18). "Press Release: Locust Walk Appoints Lubor Gaal as Senior Vice President and Head of Europe to Further Advance Global Expansion of Transactions Business". London & Boston, MA. 2018-07-11
Qiagen N.V.. (7/11/18). "Press Release: Qiagen Partners with U.K. to Expand Biomarker Research in Manchester". Manchester & Hilden. 2018-07-11
Wellcome Trust, The. (7/10/18). "Press Release: Director’s Update. Taking Risks on Bold Idease". 2018-07-10
Summit Therapeutics plc. (7/10/18). "Press Release: Summit Awarded up to $4.5 Million Grant from CARB-X for Development of New Mechanism Gonorrhoea Antibiotics". Oxford & Cambridge, MA. 2018-07-10
Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London. 2018-07-09
AMS Biotechnology (Europe) Ltd.. (7/6/18). "Press Release: AMSBIO and University of Strathclyde Jointly Launch New Screening Company". 2018-07-06
Coulter Partners. (7/5/18). "Press Release: Coulter Partners Secures Chief Executive Officer for Ovizio". 2018-07-05
Sygnature Discovery Ltd.. (7/5/18). "Press Release: Strategic Vision with the Appointment of Andy Lindstrom as Director of Marketing". 2018-07-05
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
Abzena plc. (7/2/18). "Press Release: Abzena and Telix Sign Strategic Manufacturing and Bioconjugation Agreement". Cambridge & Melbourne. 2018-07-02
Evonetix Ltd.. (7/2/18). "Press Release: Evonetix Awarded Innovate UK Funding for £1.3 Million ($1.75M) Gene Synthesis Project". Cambridge. 2018-07-02
Aptamer Group Ltd.. (6/29/18). "Press Release: Aptamer Group – UK Biotech Business Raises $2.2M Investment". York. 2018-06-29
Kymab Ltd.. (6/28/18). "Press Release: Kymab and Roche Clinical Trial Agreement for KY1044". Cambridge. 2018-06-28
Morphogen-IX Ltd.. (6/28/18). "Press Release: Morphogen-IX Appoints CEO and Forms Global Scientific Advisory Board". Cambridge. 2018-06-28
Autolus Therapeutics plc. (6/26/18). "Press Release: Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". London. 2018-06-26
NodThera Ltd.. (6/25/18). "Press Release: NodThera Secures £28 Million ($40 Million) Series A Financing". Cambridge. 2018-06-25
Autolus Therapeutics plc. (6/22/18). "Press Release: Autolus Announces Pricing of Initial Public Offering". London. 2018-06-22
PhoreMost Ltd.. (6/21/18). "Press Release: PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs". Cambridge. 2018-06-21
AdoRx Therapeutics Ltd.. (6/21/18). "Press Release: AdoRx Therapeutics Announces Initial funding of $10 Million for the Discovery of New Cancer Therapeutics". Edinburgh. 2018-06-21
Kandy Therapeutics Ltd.. (6/21/18). "Press Release: KaNDy Therapeutics and NeRRe Therapeutics Announce the Appointment of Jo Craig as Head of Chemistry Manufacturing and Controls". Stevenage. 2018-06-21
Silence Therapeutics plc. (6/21/18). "Press Release: Silence Therapeutics Strengthens Board and Leadership Team". 2018-06-21
Microsaic Systems plc. (6/21/18). "Press Release: Distribution Agreement with Amedis, spol. s ro.". 2018-06-21
Labstep Ltd.. (6/20/18). "Press Release: Seedcamp Backed ScienceTech Startup Labstep Raises £1 Million to Launch Marketplace and Double Its Team". London. 2018-06-20
Intrexon Corporation. (6/19/18). "Press Release: Oxitec to Apply New Generation of Self-Limiting Mosquito Technology to Malaria-Spreading Mosquitoes". Oxford. 2018-06-19
Freeline Therapeutics Ltd.. (6/19/18). "Press Release: Freeline Secures Over £88 Million of Funding". London. 2018-06-19
Crescendo Biologics Ltd.. (6/18/18). "Press Release: Crescendo Biologics Appoints Eva-Lotta Allan as Non-Executive Director". Cambridge. 2018-06-18
GlaxoSmithKline plc. (6/14/18). "Press Release: ViiV Healthcare Reports Landmark Phase III Studies for Dolutegravir and Lamivudine, Demonstrating the Ability to Control HIV with a Two-Drug Regimen in Treatment Naïve Patients". London. 2018-06-14
Mologic Ltd.. (6/13/18). "Press Release: Mologic and Newcastle University Launch BReD Diagnostic for Blackgrass Resistance at Cereals". Bedfordshire & Newcastle. 2018-06-13
British Business Bank. (6/13/18). "Press Release: £2.5bn British Patient Capital Programme Launched to Enable Long-term Investment in Innovative Companies across the UK". 2018-06-13
Microsaic Systems plc. (6/13/18). "Press Release: Distribution Agreement with Omicron Research Ltd.". 2018-06-13
AstraZeneca plc. (6/12/18). "Press Release: Update on Phase III Clinical Trials of Lanabecestat for Alzheimer’s Disease. Independent Data Monitoring Committee Advises Lanabecestat Is Unlikely to Meet Primary Endpoints, Leading to Decision to Discontinue 2018-06-12
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Launches Roadshow for Initial Public Offering". London. 2018-06-08
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Announces Appointment of Andrew J. Oakley as Senior Vice President and Chief Financial Officer". London. 2018-06-08
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Announces Appointment of Linda Bain to Its Board of Directors". London. 2018-06-08
Kandy Therapeutics Ltd.. (6/7/18). "Press Release: KandyTherapeutics Announces Positive Clinical Data with Lead Candidate NT-814 for the Treatment of Symptoms of the Menopause". Stevenage. 2018-06-07
Microbiotica Ltd.. (6/6/18). "Press Release: Microbiotica Enters into Microbiome Collaboration with Genentech". Cambridge. 2018-06-06
Oxford BioMedica plc. (6/6/18). "Press Release: Oxford BioMedica and Axovant Sciences Enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson’s Disease". Oxford. 2018-06-06
University of Oxford. (6/6/18). "Press Release: Rosalind Franklin Institute Will »Transform« Life Sciences Research through Disruptive Technologies". 2018-06-06
Microsaic Systems plc. (6/6/18). "Press Release: Successful Fundrainsing of £5.5 Million [N OT FOR RELEASE IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL]". 2018-06-06
Iontas Ltd.. (6/5/18). "Press Release: Iontas Signs Collaboration Agreement with LG Chem, Ltd. to Identify Therapeutic Oncology Leads". Cambridge & Seoul. 2018-06-05
Microsaic Systems plc. (6/5/18). "Press Release: Fundraising [NOT FOR UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH PROHIBITED]". 2018-06-05
Microsaic Systems plc. (6/5/18). "Press Release: PrimaryBid.com Offer [NOT FOR UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH PROHIBITED]". 2018-06-05
Peak Scientific Instruments Ltd.. (6/1/18). "Press Release: Peak Scientific Unveils an Exceptional New Gas Generator". 2018-06-01
Sygnature Discovery Ltd.. (6/1/18). "Press Release: Sygnature Discovery Focuses on US Expansion with the Appointment of Dr Bill Marathias". Nottingham. 2018-06-01
ERS Genomics Ltd.. (5/31/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices". Dublin & Reutlingen. 2018-05-31
Iontas Ltd.. (5/30/18). "Press Release: Iontas Awarded £556K ($737K) from Innovate UK to Develop Therapies for Chronic Pain Management". Cambridge. 2018-05-30
F-Star Biotechnology Ltd.. (5/30/18). "Press Release: F-Star Announces Early Exercise by Denali Therapeutics of Its Option to Acquire F-star Gamma". Cambridge. 2018-05-30
Randox Laboratories Ltd.. (5/30/18). "Press Release: The Evidence Evolution – The Newest Member of the Evidence Series". 2018-05-30
Waters Corporation. (5/29/18). "Press Release: Waters DART QDa System with LiveID Software Instantly Assesses Food Quality and Authenticity". Milford, MA. 2018-05-29
Bicycle Therapeutics Ltd.. (5/25/18). "Press Release: Bicycle Therapeutics Announces Clinical Milestone and Expands Collaboration with Thrombogenics". Cambridge & Boston, MA. 2018-05-25
Bicycle Therapeutics Ltd.. (5/24/18). "Press Release: Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca". Cambridge & Boston, MA. 2018-05-24
Orbit Discovery Ltd.. (5/23/18). "Press Release: Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing". Oxford. 2018-05-23
CN Bio Innovations Ltd.. (5/23/18). "Press Release: CN Bio Launches PhysioMimix Benchtop Human-Body-on-a-Chip Device". London. 2018-05-23
HalioDx S.A.S.. (5/22/18). "Press Release: HalioDx Signs an Agreement with Everything Genetic to Make Immunoscore Colon Assay Available in the United Kingdom". Marseille. 2018-05-22
Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel. 2018-05-21
F-Star Biotechnology Ltd.. (5/21/18). "Press Release: F-Star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody". Cambridge. 2018-05-21
Nabriva Therapeutics plc. (5/21/18). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King of Prussia, PA. 2018-05-21
Thermo Fisher Scientific Inc.. (5/16/18). "Press Release: Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development". Hillsboro, OR. 2018-05-16
Bionure. (5/16/18). "Press Release: Bionure Initiates a Phase 1 Clinical Trial of Its Lead Compound BN201 in the United Kingdom". Barcelona. 2018-05-16
PhoreMost Ltd.. (5/15/18). "Press Release: PhoreMost Completes $15M (£11M) Series A Round to Enter Drug Discovery". Cambridge. 2018-05-15
IP Group plc. (5/15/18). "Press Release: IP Group and Johns Hopkins Collaboration Funds Cancer Therapeutic Start-up". 2018-05-15
CellCentric Ltd.. (5/15/18). "Press Release: CellCentric Raises $26 Million to Take First-in-Class p300/CBP Inhibitor into the Clinic". 2018-05-15
Applied Photophysics Ltd.. (5/15/18). "Press Release: Applied Photophysics Signs Agreements with Alfatest and Paralab to Expand Distribution in Europe". Surrey, Rome & Valborn. 2018-05-15
Premaitha Health plc. (5/15/18). "Press Release: Year-end Trading Update and £2.5m Fundraising". Manchester. 2018-05-15
Brainomix Ltd.. (5/11/18). "Press Release: Brainomix Announces CE Mark Certification for New e-CTA Software". Oxford. 2018-05-11
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

» top